Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Gastpar

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
The International Journal of Neuropsychopharmacology|January 21, 2004
Safety and efficacy of combined clozapine-lithium pharmacotherapyStefan Bender, Thomas Linka, Jörg Wolstein, et al.
International Clinical Psychopharmacology|June 24, 2010
Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depressionSiegfried Kasper, Markus Gastpar, Hans-Juergen Möller, et al.
The International Journal of Neuropsychopharmacology|January 25, 2014
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetineSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
Wiener Medizinische Wochenschrift (1946)|December 21, 2010
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trialsSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
International Clinical Psychopharmacology|June 1, 2010
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trialSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
Neuropsychobiology|April 30, 2002
Concomitant endocrine and immune alterations during alcohol intoxication and acute withdrawal in alcohol-dependent subjectsSven Kutscher, Dirk J Heise, Markus Banger, et al.
Clinical Chemistry and Laboratory Medicine|July 21, 2004
Urine labeling with orally applied marker substances in drug substitution therapyBernd Huppertz, Gisela Gauchel, Heribert Feiertag, et al.
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Management of acutely ill patients in the hospital setting: focus on quetiapineJoseph Peuskens, Siegfried Kasper, Celso Arango, et al.
Journal of Clinical Psychopharmacology|November 28, 2002
Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter studyMarkus Gastpar, Udo Bonnet, Jobst Böning, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trialUdo Bonnet, Markus Banger, F Markus Leweke, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The International Journal of Neuropsychopharmacology|January 21, 2004
Safety and efficacy of combined clozapine-lithium pharmacotherapyStefan Bender, Thomas Linka, Jörg Wolstein, et al.
International Clinical Psychopharmacology|June 24, 2010
Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depressionSiegfried Kasper, Markus Gastpar, Hans-Juergen Möller, et al.
The International Journal of Neuropsychopharmacology|January 25, 2014
Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetineSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
Wiener Medizinische Wochenschrift (1946)|December 21, 2010
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trialsSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
International Clinical Psychopharmacology|June 1, 2010
Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trialSiegfried Kasper, Markus Gastpar, Walter E Müller, et al.
Neuropsychobiology|April 30, 2002
Concomitant endocrine and immune alterations during alcohol intoxication and acute withdrawal in alcohol-dependent subjectsSven Kutscher, Dirk J Heise, Markus Banger, et al.
Clinical Chemistry and Laboratory Medicine|July 21, 2004
Urine labeling with orally applied marker substances in drug substitution therapyBernd Huppertz, Gisela Gauchel, Heribert Feiertag, et al.
International Journal of Psychiatry in Clinical Practice|June 19, 2014
Management of acutely ill patients in the hospital setting: focus on quetiapineJoseph Peuskens, Siegfried Kasper, Celso Arango, et al.
Journal of Clinical Psychopharmacology|November 28, 2002
Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter studyMarkus Gastpar, Udo Bonnet, Jobst Böning, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trialUdo Bonnet, Markus Banger, F Markus Leweke, et al.
Pageof 6